Stay updated on Ublituximab in RMS: Clinical Trial
Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.

Latest updates to the Ublituximab in RMS: Clinical Trial page
- Check3 days agoChange DetectedA consolidated 'Locations' section lists participating states (Arizona, Colorado, Florida, Kentucky, Missouri, Nevada, New Jersey, New Mexico, New York, Ohio, Pennsylvania, Texas, Washington) and the prior state-specific location subsections were removed, restructuring how trial sites are presented.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedPublications note updated to indicate items are automatically filled in from PubMed and that PubMed is a public database; Revision: v3.3.2.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding status notice banner. Core study information, eligibility criteria, endpoints, and trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedNo substantive changes to the study details were observed between screenshots; core information remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a government-funding/status notice and upgraded version to v3.2.0; removed the old v3.1.0 tag.SummaryDifference4%

- Check90 days agoChange DetectedNew version tag v3.1.0 added and several MedlinePlus topics removed (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); older version tag v3.0.2 removed. Core page content and topic scope updated accordingly.SummaryDifference0.6%

Stay in the know with updates to Ublituximab in RMS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.